Formed in January, PharmaLedger is a 29 member blockchain consortium, including 12 global pharmaceutical companies. It aims to enable healthcare innovation for supply chain, clinical trials and health data.
The initiative is a three year project sponsored by the EU-backed Innovative Medicines Initiative (IMI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Horizon 2020 program. The combined budget is more than €20 million ($22m) of which a maximum of €8.33 million ($9.3m) will be contributed by the IMI. Back in August 2018, we wrote about the IMI call for proposals for “Blockchain enabled healthcare“, now known under the project title “PharmaLedger”.
Despite the focus on the three domains, PharmaLedger is keen to emphasize that the blockchain platform aims to serve any use case in the healthcare industry.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
